Please login to the form below
90TEN appoints Alison Doughty as med ed MD
She joins from Ketchum where she was a partner and director
Global healthcare communications agency, 90TEN has appointed Alison Doughty as its managing director, medical education division following a year of unprecedented growth for the Battersea, UK-based agency.
Previously serving Ketchum as its partner and director, Doughty has overseen health PR teams and founded med ed agency Inspired Science.
Carole North, 90TEN’s co-founder and chief executive officer, said: “We have long admired Alison’s entrepreneurial flare and talent for breaking new ground in healthcare communications, and we are thrilled to welcome her to 90TEN.
“Our medical education team has had a record-breaking year, winning new clients in the US and Europe, and there couldn’t be a better time for Alison to bring her combination of scientific expertise and strategic nous to the mix.”
Doughty has also previously worked for MedITech Media, Health Interactions and Roche.
Subscribe to our email news alerts
- World AIDS Day 35: Medscape’s Commitment to the Elimination of HIV through Education and Looking Towards the Future
- No “White Space” Between Live Meetings; the top 10 benefits of virtual advisory boards
- Building trust with HCPs: 6 takeaways from our industry webinar
- Eli Lilly and PRISM BioLab enter drug discovery collaboration worth over $660m
- NHS to offer stem cell transplants to patients living with rare blood disorder
- First WHO Global Clinical Trial Forum develops joint vision to improve clinical research
No results were found
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
